{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:19:12Z","timestamp":1779149952189,"version":"3.51.4"},"reference-count":29,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:00:00Z","timestamp":1027555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2002,8]]},"abstract":"<jats:p><jats:bold>Summary.<\/jats:bold> The CD95 (Fas) molecule transmits apoptotic signals important in B\u2010cell development and the genesis of B\u2010cell lymphoma. We have investigated the surface and intracellular expression of CD95 in Burkitt's lymphoma (BL) cells, an important non\u2010Hodgkin's lymphoma of B\u2010cell origin. Group I BL cells did not express CD95 at the cell surface, but contained high levels of this receptor in the cytoplasm. In contrast, group III BL cells expressed CD95 intracellularly and at the cell surface. In group I and group III BL cells, cytoplasmic CD95 was localized to the Golgi complex, as assessed by confocal immunofluorescence microscopy and subcellular fractionation followed by immunoblotting. Trafficking through the Golgi complex is regulated by elements within the target protein and cellular sorting mechanisms. CD95 contains candidate signals for interaction with trafficking machinery. Group I BL cells can be induced to upregulate surface expression of CD95 following CD40 ligation and certain group I BL cell lines drift <jats:italic>invitro<\/jats:italic> to a group III phenotype, with consequent surface expression of CD95. Taken together, these observations show that CD95 can either be retained in the Golgi complex or exported to the cell surface, and suggest that membrane trafficking has an important and previously unrecognized role in regulating CD95 expression in B lymphocytes.<\/jats:p>","DOI":"10.1046\/j.1365-2141.2002.03643.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T06:46:33Z","timestamp":1047365193000},"page":"488-494","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["CD95 (Fas) expression is regulated by sequestration in the Golgi complex in B\u2010cell lymphoma"],"prefix":"10.1111","volume":"118","author":[{"given":"Andrew P.","family":"Haynes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdulmunem M.","family":"Abhulayha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Ian","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Metheringham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D.","family":"Gregory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,7,25]]},"reference":[{"key":"e_1_2_5_2_1","first-page":"599","volume-title":"Molecular Biology of the Cell.","author":"Alberts B.","year":"1994"},{"key":"e_1_2_5_3_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.281.5381.1305"},{"key":"e_1_2_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80881-8"},{"key":"e_1_2_5_5_1","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1182\/blood.V79.12.3300.bloodjournal79123300","article-title":"Expression of the APO\u20101 antigen in Burkitt's lymphoma cell lines correlates with a shift towards towards a lymphoblastoid phenotype","volume":"79","author":"Falk M.H.","year":"1992","journal-title":"Blood"},{"key":"e_1_2_5_6_1","doi-asserted-by":"crossref","first-page":"313","DOI":"10.4049\/jimmunol.139.1.313","article-title":"Identification of a subset of normal B\u2010cells with a Burkitt's lymphoma (BL)\u2010like phenotype","volume":"139","author":"Gregory C.D.","year":"1987","journal-title":"Journal of Immunology"},{"key":"e_1_2_5_7_1","first-page":"696","article-title":"Bax is frequently compromised in Burkitt's lymphomas with irreversible resistance to Fas\u2010induced apoptosis","volume":"59","author":"Gutierrez M.I.","year":"1999","journal-title":"Cancer Research"},{"key":"e_1_2_5_8_1","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.4049\/jimmunol.162.2.1042","article-title":"TNF recruits TRADD to the plasma membrane but not the trans\u2010Golgi network, the principal subcellular location of TNF\u2010R1","volume":"162","author":"Jones S.J.","year":"1999","journal-title":"Journal of Immunology"},{"key":"e_1_2_5_9_1","doi-asserted-by":"publisher","DOI":"10.3109\/08830189909088495"},{"key":"e_1_2_5_10_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01792.x"},{"key":"e_1_2_5_11_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.116.5.1071"},{"key":"e_1_2_5_12_1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein estimation with folin\u2010phenol reagent","volume":"193","author":"Lowry O.H.","year":"1951","journal-title":"Journal of Biological Chemistry"},{"key":"e_1_2_5_13_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.190.7.1033"},{"key":"e_1_2_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0962-8924(98)01382-8"},{"key":"e_1_2_5_15_1","first-page":"847","article-title":"Expression of CD95 antigen and Bcl\u20102 protein in non\u2010Hodgkin's lymphomas and Hodgkin's disease","volume":"148","author":"Nguyen P.L.","year":"1996","journal-title":"American Journal of Pathology"},{"key":"e_1_2_5_16_1","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1182\/blood.V91.8.2875.2875_2875_2885","article-title":"Tumor B\u2010cells from non\u2010Hodgkin's lymphoma are resistant to CD95 (Fas\/Apo\u20101)\u2010mediated apoptosis","volume":"8","author":"Plumas J.","year":"1998","journal-title":"Blood"},{"key":"e_1_2_5_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3495(97)78662-4"},{"key":"e_1_2_5_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81349-5"},{"key":"e_1_2_5_19_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.9.5.1107"},{"key":"e_1_2_5_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/374163a0"},{"key":"e_1_2_5_21_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.32.22532"},{"key":"e_1_2_5_22_1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.182.5.1557"},{"key":"e_1_2_5_23_1","doi-asserted-by":"crossref","unstructured":"Storrie B.&Madden E.A.(1990)Methods in Enzymology(ed. byM. P.Deutscher) Vol. 182 p.203.Academic Press London.","DOI":"10.1016\/0076-6879(90)82018-W"},{"key":"e_1_2_5_24_1","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1182\/blood.V94.5.1727","article-title":"Modulation of caspase\u20108 and FLICE\u2010inhibitory protein expressions as a potential mechanism of Epstein\u2010Barr virus tumorigenesis in Burkitt's lymphoma","volume":"94","author":"Tepper C.G.","year":"1999","journal-title":"Blood"},{"key":"e_1_2_5_25_1","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.cb.09.110193.001021","article-title":"Signal dependent membrane protein trafficking in the endocytic pathway","volume":"9","author":"Trowbridge I.S.","year":"1993","journal-title":"Annual Reviews in Cell Biology"},{"key":"e_1_2_5_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/364645a0"},{"key":"e_1_2_5_27_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.122.1.39"},{"key":"e_1_2_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81420-8"},{"key":"e_1_2_5_29_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.422688.x"},{"key":"e_1_2_5_30_1","doi-asserted-by":"publisher","DOI":"10.3109\/08830189909088489"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03643.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2141.2002.03643.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2141.2002.03643.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:10:33Z","timestamp":1697422233000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2141.2002.03643.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,7,25]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,8]]}},"alternative-id":["10.1046\/j.1365-2141.2002.03643.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03643.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,7,25]]},"assertion":[{"value":"2002-07-25","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}